BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Sep 27, 2025; 17(9): 110347
Published online Sep 27, 2025. doi: 10.4240/wjgs.v17.i9.110347
Table 1 Demographic characteristics of the study population, mean ± SD/n (%)
Parameters
HFE (n = 107)
CSP (n = 106)
EMR (n = 108)
P1 value
P2 value
P3 value
Age (years)57.90 ± 13.2056.80 ± 11.6157.29 ± 12.351.5512.2892.172
Gender2.8472.6582.505
Male57 (53.27)56 (53.27)56 (51.85)
Female50 (46.73)50 (46.73)52 (48.15)
Smoking22 (20.56)22 (20.56)22 (20.37)2.9162.8352.916
Drinking35 (79.44)38 (32.71)38 (35.18)1.8872.7572.106
Course of disease, months14.24 ± 2.4514.31 ± 2.2514.08 ± 2.922.5171.5571.989
Hypertension20 (18.69)21 (19.81)22 (20.37)2.5082.7572.268
Diabetes11 (10.28)10 (9.43)13 (12.03)2.5081.6172.049
Hyperlipidemia20 (18.69)22 (20.75)23 (21.29)2.1152.7691.899
Coronary heart disease8 (7.48)6 (5.89)8 (7.15)1.7791.8152.955
Indication2.7962.8322.904
Screening33 (30.84)36 (33.96)35 (32.63)
Follow up19 (17.76)16 (15.09)21 (19.44)
For polypectomy22 (20.56)22 (20.75)22 (19.45)
Positive FOBT6 (5.61)8 (7.55)7 (6.48)
Symptoms27 (25.23)24 (22.64)23 (21.29)
Bowel preparation2.2352.1993.000
BBPS < 65 (4.67)6 (5.66)5 (4.62)
BBPS ≥ 6102 (95.33)100 (94.34)103 (95.38)
Table 2 Preoperative laboratory blood tests, mean ± SD
Parameters
HFE (n = 107)
CSP (n = 106)
EMR (n = 108)
P1 value
P2 value
P3 value
Prothrombin time (seconds)11.54 ± 1.0211.25 ± 1.7311.73 ± 1.450.8370.0930.759
White blood cell count (× 109/L)5.89 ± 1.125.74 ± 1.285.52 ± 1.341.1040.6330.090
Platelet count (× 109/L)205.37 ± 54.99208.37 ± 52.75211.76 ± 51.842.0551.9051.146
Hemoglobin (g/L)147.63 ± 16.93145.72 ± 14.13144.72 ± 16.211.1131.8870.597
Table 3 Clinical characteristics of the polyps, n (%)
Parameters
HFE (n = 107)
CSP (n = 106)
EMR (n = 108)
P1 value
P2 value
P3 value
Polyp diameter (mm)10.61 ± 2.257.89 ± 2.12c14.20 ± 1.65c,e< 0.001< 0.001< 0.001
Location1.8240.8572.214
Proximal colon65 (60.75)68 (64.15)68 (62.96)
Distal colon42 (39.25)38 (35.85)40 (37.04)
Morpholog1.0680.9191.227
Flat32 (29.91)38 (35.85)38 (35.18)
Protruded75 (70.09)68 (64.15)70 (64.82)
Histopathology2.5230.8501.809
TA with LGD104 (97.2)101 (95.28)101 (93.52)
TA with HGD1 (0.93)1 (0.94)3 (2.78)
TVA1 (0.93)1 (0.94)1 (0.92)
SSA/P1 (0.93)3 (2.83)3 (2.78)
Table 4 Surgical details, mean ± SD/n (%)
Parameters
HFE (n = 107)
CSP (n = 106)
EMR (n = 108)
P1 value
P2 value
P3 value
Total procedure time (minutes)29.38 ± 2.1132.58 ± 2.24c31.34 ± 2.35c,e< 0.001< 0.001< 0.001
Prophylactic clip use10 (9.35)1 (0.94)b3 (2.77)0.0180.6270.129
Operator experience0.2070.5300.654
Experienced endoscopist106 (99.07)99 (93.4)103 (95.37)
Non-experienced endoscopist1 (0.93)7 (6.6)5 (4.63)
Intraoperative bleeding (mL)4.18 ± 0.254.16 ± 0.294.22 ± 0.131.8060.1620.264
Hospital time (days)0.96 ± 0.580.82 ± 0.440.97 ± 0.560.1140.0902.703
Table 5 Resection rate, n (%)
Parameters
HFE (n = 107)
CSP (n = 106)
EMR (n = 108)
P1 value
P2 value
P3 value
En bloc resection491 (85.05)95 (89.62)77 (71.30)a,e0.948< 0.0010.045
R0 resection587 (81.31)65 (61.32)b79 (73.14)0.0030.1950.462
R1 resection620 (18.69)22 (20.75)30 (27.78)2.1150.6930.345
Rx resection717 (15.89)16 (15.09)16 (14.81)2.6192.8622.481
Ulcer base diameter one week after treatment (mm)4.84 ± 1.023.19 ± 0.66c3.52 ± 0.85c,d< 0.0010.006< 0.001